By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Spring Bank Pharmaceuticals, Inc. 

113 Cedar Street
Ste S-7
Milford  Massachusetts  01757  U.S.A.
Phone: 508-473-5993 Fax: n/a


SEARCH JOBS


Industry
Pharmaceutical

Segment
Pharmaceuticals





Company News
Spring Bank Pharmaceuticals, Inc. Abstracts On STING Agonist SB 11285 Accepted For Poster Presentations At AACR Special Conference On Tumor Immunology And Immunotherapy 9/7/2016 10:07:58 AM
Spring Bank Pharmaceuticals, Inc. To Present At The 18th Annual Rodman & Renshaw Global Investment Conference In New York City On September 13th, 2016 8/23/2016 8:03:47 AM
Spring Bank Pharmaceuticals, Inc. To Ring The Nasdaq Stock Market Opening Bell 8/2/2016 8:39:24 AM
Spring Bank Pharmaceuticals, Inc. Appoints Dr. Todd C. Brady To Its Board Of Directors 7/29/2016 8:29:14 AM
Spring Bank Pharmaceuticals, Inc. Reports Preclinical Data On The Use Of SB 9200 With Entecavir In The Woodchuck Model Of HBV 12/8/2015 11:46:30 AM
Spring Bank Pharmaceuticals, Inc. Announces Clinical Trial Collaboration With Gilead (GILD) For Hepatitis B (HBV) Phase 2 Clinical Trial 11/19/2015 6:12:21 AM
Spring Bank Pharmaceuticals, Inc. Presents Positive Phase 1 Data On SB 9200 At The 2015 American Association For The Study Of Liver Diseases Annual Meeting 11/16/2015 7:38:06 AM
Spring Bank Pharmaceuticals, Inc. Names Nezam Afdhal, MD As Chief Medical Officer 11/9/2015 8:24:28 AM
Spring Bank Pharmaceuticals, Inc. Announces Presentation Of Results From Phase I Clinical Trial Supporting The Novel Mechanism Of Action Of SB 9200 In Patients With Hepatitis C At The Liver Meeting 10/13/2015 7:01:21 AM
Spring Bank Pharmaceuticals, Inc. Appoints Martin Driscoll As President And Chief Executive Officer 8/17/2015 6:38:27 AM
123
//-->